These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8293965)

  • 1. Effect of miconazole on the structure and function of plasma membrane of Candida albicans.
    Ansari S; Prasad R
    FEMS Microbiol Lett; 1993 Nov; 114(1):93-8. PubMed ID: 8293965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of miconazole on ergosterol-less mutant of Candida albicans.
    Pesti M; Becher D; Bartsch G
    Acta Microbiol Hung; 1983; 30(1):25-9. PubMed ID: 6362313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action.
    Vanden Bossche H
    Curr Top Med Mycol; 1985; 1():313-51. PubMed ID: 3916772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of terconazole and other azole antifungal agents on the sterol and carbohydrate composition of Candida albicans.
    Pfaller MA; Riley J; Koerner T
    Diagn Microbiol Infect Dis; 1990; 13(1):31-5. PubMed ID: 2184984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans.
    van den Bossche H; Willemsens G; Cools W; Lauwers WF; Le Jeune L
    Chem Biol Interact; 1978 Apr; 21(1):59-78. PubMed ID: 352553
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of supplementation of ergosterol on miconazole action in vivo and in vitro in Candida albicans.
    Mago N; Khuller GK
    Indian J Exp Biol; 1991 Sep; 29(9):841-4. PubMed ID: 1794867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans.
    Georgopapadakou NH; Dix BA; Smith SA; Freudenberger J; Funke PT
    Antimicrob Agents Chemother; 1987 Jan; 31(1):46-51. PubMed ID: 3551826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of mutants of Candida glabrata resistant to miconazole.
    Nicholas RO; Burton JA; Kerridge D; Wayman FJ
    Crit Rev Microbiol; 1987; 15(1):103-10. PubMed ID: 3691159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antifungal agents on ergosterol biosynthesis in Candida albicans and Trichophyton mentagrophytes: differential inhibitory sites of naphthiomate and miconazole.
    Morita T; Nozawa Y
    J Invest Dermatol; 1985 Nov; 85(5):434-7. PubMed ID: 3902987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the cellular composition of Candida albicans resistant to miconazole.
    Sharma S; Khuller GK
    Indian J Biochem Biophys; 1996 Oct; 33(5):420-4. PubMed ID: 9029825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to amphotericin B and miconazole.
    Eshwika A; Coyle B; Devereux M; McCann M; Kavanagh K
    Biometals; 2004 Aug; 17(4):415-22. PubMed ID: 15259362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of inhibition of sterol synthesis with growth-inhibitory action of imidazole antimycotics in Candida albicans.
    Nicholas RO; Kerridge D
    J Antimicrob Chemother; 1989 Jan; 23(1):7-19. PubMed ID: 2663807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between ethanol tolerance, lipid composition and plasma membrane fluidity in Saccharomyces cerevisiae and Kloeckera apiculata.
    Alexandre H; Rousseaux I; Charpentier C
    FEMS Microbiol Lett; 1994 Nov; 124(1):17-22. PubMed ID: 8001764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of Candida albicans to direct lethal miconazole action induced by low-level miconazole.
    Beggs WH
    Mycoses; 1991; 34(5-6):227-30. PubMed ID: 1795717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct in vivo interaction of the antibiotic primycin with the plasma membrane of Candida albicans: an EPR study.
    Virág E; Belagyi J; Gazdag Z; Vágvölgyi C; Pesti M
    Biochim Biophys Acta; 2012 Jan; 1818(1):42-8. PubMed ID: 21978596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mode of action of miconazole on Candida albicans: effect on growth, viability and K+ release.
    Cope JE
    J Gen Microbiol; 1980 Jul; 119(1):245-51. PubMed ID: 6997434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Status of membrane lipids and amino acid transport in morphological mutants of Candida albicans.
    Koul A; Chandra J; Prasad R
    Biochem Mol Biol Int; 1995 May; 35(6):1215-22. PubMed ID: 7492959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid increases antifungal susceptibility of Candida albicans and Candida dubliniensis.
    Ells R; Kock JL; Van Wyk PW; Botes PJ; Pohl CH
    J Antimicrob Chemother; 2009 Jan; 63(1):124-8. PubMed ID: 18971215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of altered ergosterol content on the transport of various amino acids in Candida albicans.
    Singh M; Jayakumar A; Prasad R
    Biochim Biophys Acta; 1979 Jul; 555(1):42-55. PubMed ID: 383149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.